Literature DB >> 29411190

Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention.

Susanna Esposito1, Nicola Principi2.   

Abstract

For a long time, hand, foot and mouth disease (HFMD) was seen as a mild viral infection characterized by typical clinical manifestations that spontaneously resolved in a few days without complications. In the past two decades, HFMD has received new attention because of evidence that this disease could have clinical, epidemiological and aetiological characteristics quite different from those initially thought. In contrast to previous beliefs, it has been clarified that HFMD can be associated with complications, leading to severe neurological sequelae and, rarely, to death. This finding has led to an enormous number of studies that have indicated that several viruses in addition to those known to be causes of HFMD could be associated with the development of disease. Moreover, it was found that if some viruses were more common in some geographic areas, frequent modification of the molecular epidemiology of the infecting strains could lead to outbreaks caused by infectious agents significantly different from those previously circulating. Vaccines able to confer protection against the most common aetiologic agents in a given country have been developed. However, simultaneous circulation of more than one causative virus and modification of the molecular epidemiology of infectious agents make preparations based on a single agent relatively inadequate. Vaccines with multiple components are a possible solution. However, several problems concerning their development must be solved before adequate prevention of severe cases of HFMD can be achieved.

Entities:  

Mesh:

Year:  2018        PMID: 29411190     DOI: 10.1007/s10096-018-3206-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  104 in total

1.  An enterovirus 71 epidemic in Guangdong Province of China, 2008: epidemiological, clinical, and virogenic manifestations.

Authors:  Li-mei Sun; Huan-ying Zheng; Hui-zhen Zheng; Xue Guo; Jian-feng He; Da-wei Guan; Min Kang; Zheng Liu; Chang-wen Ke; Jian-sen Li; Leng Liu; Ru-ning Guo; Hiromu Yoshida; Jin-yan Lin
Journal:  Jpn J Infect Dis       Date:  2011       Impact factor: 1.362

2.  Hand, foot, and mouth disease in China, 2008-12: an epidemiological study.

Authors:  Weijia Xing; Qiaohong Liao; Cécile Viboud; Jing Zhang; Junling Sun; Joseph T Wu; Zhaorui Chang; Fengfeng Liu; Vicky J Fang; Yingdong Zheng; Benjamin J Cowling; Jay K Varma; Jeremy J Farrar; Gabriel M Leung; Hongjie Yu
Journal:  Lancet Infect Dis       Date:  2014-01-31       Impact factor: 25.071

3.  Epidemiology of hand, foot, and mouth disease in children in Shanghai 2007-2010.

Authors:  M Zeng; Y-F Li; X-H Wang; G-P Lu; H-G Shen; H Yu; Q-R Zhu
Journal:  Epidemiol Infect       Date:  2011-08-31       Impact factor: 2.451

Review 4.  Virology, epidemiology, pathogenesis, and control of enterovirus 71.

Authors:  Tom Solomon; Penny Lewthwaite; David Perera; Mary Jane Cardosa; Peter McMinn; Mong How Ooi
Journal:  Lancet Infect Dis       Date:  2010-10-18       Impact factor: 25.071

5.  Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema.

Authors:  Thomas Hubiche; Isabelle Schuffenecker; Franck Boralevi; Christine Léauté-Labrèze; Laure Bornebusch; Christine Chiaverini; Alice Phan; Annabel Maruani; Juliette Miquel; Marie-Edith Lafon; Bruno Lina; Pascal Del Giudice
Journal:  Pediatr Infect Dis J       Date:  2014-04       Impact factor: 2.129

6.  Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain.

Authors:  M Cabrerizo; D Tarragó; C Muñoz-Almagro; E Del Amo; M Domínguez-Gil; J M Eiros; I López-Miragaya; C Pérez; J Reina; A Otero; I González; J E Echevarría; G Trallero
Journal:  Clin Microbiol Infect       Date:  2013-09-14       Impact factor: 8.067

Review 7.  Clinical features, diagnosis, and management of enterovirus 71.

Authors:  Mong How Ooi; See Chang Wong; Penny Lewthwaite; Mary Jane Cardosa; Tom Solomon
Journal:  Lancet Neurol       Date:  2010-11       Impact factor: 44.182

8.  The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore.

Authors:  Li-Wei Ang; Meng-Chee Phoon; Yan Wu; Jeffery Cutter; Lyn James; Vincent T Chow
Journal:  BMC Infect Dis       Date:  2011-10-11       Impact factor: 3.090

9.  Coxsackievirus A6 and hand, foot, and mouth disease, Finland.

Authors:  Riikka Osterback; Tytti Vuorinen; Mervi Linna; Petri Susi; Timo Hyypiä; Matti Waris
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

10.  Association study of inflammatory cytokine and chemokine expression in hand foot and mouth disease.

Authors:  Wenzhong Shang; Suying Qian; Lijuan Fang; Yong Han; Cuiping Zheng
Journal:  Oncotarget       Date:  2017-06-02
View more
  29 in total

1.  Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial.

Authors:  Xiaoyu Liu; Wanqi Yang; Chao Zhang; Heng Wu; Ruize Wang; Qiang Ding; Yan Hu; Yongli Xiong; Shaobai Zhang; Lin Wang
Journal:  Hum Vaccin Immunother       Date:  2021-12-14       Impact factor: 3.452

2.  Analysis of the long noncoding RNA profiles of RD and SH-SY5Y cells infected with coxsackievirus B5, using RNA sequencing.

Authors:  Peiying Teng; Heng Yang; Jing Li; Fan Yang; Wei Chen
Journal:  Arch Virol       Date:  2021-11-28       Impact factor: 2.574

3.  Assessing the impact of ambient temperature on the risk of hand, foot, and mouth disease in Guangdong, China: New insight from the disease severity and burden.

Authors:  Zhicheng Du; Wangjian Zhang; Shicheng Yu; Shao Lin; Yuantao Hao
Journal:  PLoS Negl Trop Dis       Date:  2022-06-23

4.  EV71 vaccination impact on the incidence of encephalitis in patients with hand, foot and mouth disease.

Authors:  Jian Li; Xiuzhi Yin; Aiwei Lin; Xiuzhen Nie; Liyan Liu; Shihua Liu; Na Li; Ping Wang; Shuangshuang Song; Shaoning Wang; Daoyan Xu
Journal:  Hum Vaccin Immunother       Date:  2021-01-31       Impact factor: 3.452

5.  Epidemiological characteristics of hand, foot, and mouth disease in China: A meta-analysis.

Authors:  Bo Chen; Ying Yang; Xufeng Xu; Haixia Zhao; Yi Li; Shi Yin; Yong-Quan Chen
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

6.  Infectious dermatoses that can manifest as vesicles.

Authors:  Yongxuan Hu
Journal:  Infect Drug Resist       Date:  2019-09-27       Impact factor: 4.003

7.  Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study.

Authors:  Chonnamet Techasaensiri; Artit Wongsa; Thanyawee Puthanakit; Kulkanya Chokephaibulkit; Tawee Chotpitayasunondh; Ubonwon Charoonruangrit; Somjai Sombatnimitsakul; Pilaipan Puthavathana; Hatairat Lerdsamran; Prasert Auewarakul; Boonrat Tassaneetrithep
Journal:  Pathogens       Date:  2021-05-19

8.  Coxsackievirus A16 in Southern Vietnam.

Authors:  Le Nguyen Truc Nhu; Le Nguyen Thanh Nhan; Nguyen To Anh; Nguyen Thi Thu Hong; Hoang Minh Tu Van; Tran Tan Thanh; Vu Thi Ty Hang; Do Duong Kim Han; Nguyen Thi Han Ny; Lam Anh Nguyet; Du Tuan Quy; Phan Tu Qui; Truong Huu Khanh; Nguyen Thanh Hung; Ha Manh Tuan; Nguyen Van Vinh Chau; Guy Thwaites; H Rogier van Doorn; Le Van Tan
Journal:  Front Microbiol       Date:  2021-06-24       Impact factor: 5.640

9.  Epidemiological and clinical characteristics of severe hand-foot-and-mouth disease (HFMD) among children: a 6-year population-based study.

Authors:  Yanhao Wang; Han Zhao; Rong Ou; Hua Zhu; Lidan Gan; Zihuan Zeng; Ruizhu Yuan; Huan Yu; Mengliang Ye
Journal:  BMC Public Health       Date:  2020-05-27       Impact factor: 3.295

10.  Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China.

Authors:  Jia Xie; Xiao-Han Yang; Si-Qi Hu; Wen-Li Zhan; Chang-Bin Zhang; Hong Liu; Hong-Yu Zhao; Hui-Ying Chai; Ke-Yi Chen; Qian-Yi Du; Pan Liu; Ai-Hua Yin; Ming-Yong Luo
Journal:  BMC Infect Dis       Date:  2020-04-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.